Vnitr Lek 2026, 72(5):342-344 | DOI: 10.36290/vnl.2026.066

Flu vaccination - common myths and how to talk to patients

Šárka Rumlarová
Centrum očkování a cestovní medicíny, Klinika infekčních nemocí, Fakultní nemocnice Hradec Králové a Univerzita Karlova, Lékařská fakulta v Hradci Králové

Influenza is a highly contagious disease that can lead to serious complications. Vaccination against influenza clearly reduces the risk of infection or a severe course of the illness. Despite the fact that its effectiveness is reliably supported by extensive data, the Czech population has long shown distrust toward influenza vaccination. Vaccination coverage in the Czech Republic is lamentably low, even among high-risk patient groups. This article examines the most common objections cited as reasons for refusing the influenza vaccine and provides appropriate arguments to counter these concerns. These may help in discussions with patients and contribute to improving the situation regarding influenza vaccination.

Keywords: influenza, vaccination, vaccination refusal, risk groups of patients.

Accepted: August 20, 2026; Published: August 27, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rumlarová Š. Flu vaccination - common myths and how to talk to patients. Vnitr Lek. 2026;72(5):342-344. doi: 10.36290/vnl.2026.066.
Download citation

References

  1. Beneš J. Infekční lékařství. 1. vyd. Praha: Galén; 2009.
  2. Havlíčková M, Druelles S, Jirincova H, et al. Circulation of influenza A and B in the Czech Republic from 2000-2001 to 2015-2016. BMC Infect Dis. 2019;19(1):1-10. Go to original source... Go to PubMed...
  3. Beran J, Havlík J, Vonka V. Očkování. Minulost, přítomnost, budoucnost. 1. vyd. Praha: Galén; 2005.
  4. Rumlarová Š, Chmelař J, Šmahel P, et al. Život ohrožující komplikace chřipky u adolescenta. Vakcinologie. 2021;15(1):32-36.
  5. Kynčl J, Šimka V, Manďáková Z. Chřipka - závažné, očkováním preventabilní onemocnění. Remedia. 2023;33:330-335.
  6. ČVS ČL JEP. Doporučení České vakcinologické společnosti ČLS JEP k očkování proti chřipce [Internet]. 2025 [cited 2026 Mar 15]. Available from: https://vakcinace.eu/doporuceni-a-stanoviska/doporuceni-ceske-vakcinologicke-spolecnosti-cls-jep-k-ockovani-proti-chripce-4
  7. WHO. Vaccines against influenza: WHO position paper - May 2022 [Internet]. WHO; 2022 [cited 2026 Mar 15]. Available from: https://www.who.int/publications/i/item/who-wer9719
  8. Chlíbek R, et al. Očkování dospělých. 2. vyd. Praha: Mladá fronta; 2019.
  9. WHO. Prevention and control of influenza pandemics and annual epidemics. Fifty-sixth World Health Assembly [Internet]. WHO; 2003 [cited 2026 Mar 16]. Available from: https://apps.who.int/gb/archive/pdf_files/wha56/ea56r19.pdf
  10. ÚZIS ČR. Aktuální data o proočkovanosti české populace. Národní zdravotnický informační systém; [Internet]. 2025 [cited 2026 Mar 21]. Available from: https://www.nzip.cz/data/ceo/analyticke-studie/ceo-vakcinace-prehled/ceo-vakcinace-prehled.pdf
  11. Cikrt T. Výzva: Zdravotníci, braňte očkování. Nebo vraťte diplomy [Internet]. Zdravotnický deník; 2026 [cited 2026 Mar 21]. Available from: https://www.zdravotnickydenik.cz/2026/03/vyzva-zdravotnici-brante-ockovani/
  12. Pavlasová L, Vojíř K. Influenza and influenza vaccination from the perspective of Czech pre-service teachers: knowledge and attitudes. Cent Eur J Public Health. 2021;29(3):177-182. Go to original source... Go to PubMed...
  13. Kyncl J, Brabec M, Maly M, et al. Influenza-related deaths in the Czech Republic over 21 seasons. Influenza Other Respir Viruses. 2025 Mar 6;19(3). doi:10.1111/irv.70072 Go to original source... Go to PubMed...
  14. Dušek L, Horecký J. Elektronizace očkování a její přínosy: nové služby pro občany. Konference v Senátu PČR; 2025 Sep 17. Report.
  15. Cao H, Lv J, Li X, et al. Efficacy of influenza vaccines and its relationship with immunological surrogate endpoints: a systematic review and meta-analysis of randomized controlled trial. Clin Microbiol Infect. 2026;32(1):30-40. Go to original source... Go to PubMed...
  16. Lewis NM, Zhu Y, Peltan ID, et al. Vaccine effectiveness against influenza A-associated hospitalization, organ failure, and death: United States, 2022-2023. Clin Infect Dis. 2024;78(4):1056-1064. Go to original source... Go to PubMed...
  17. Whitaker HJ, Kirsebom FCM, Hassell K, et al. Effectiveness of influenza vaccines and duration of protection against hospitalisation in England: 2022/2023 and 2023/2024 seasons. Influenza Other Respir Viruses. 2025;19(12):doi:10.1111/irv.70194. Go to original source...
  18. Ferdinands JM, Gaglani M, Martin ET, et al. Waning vaccine effectiveness against influenza-associated hospitalizations among adults, 2015-2016 to 2018-2019, United States Hospitalized Adult Influenza Vaccine Effectiveness Network. Clin Infect Dis. 2021;73(4):726-729. Go to original source...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.